A device and system for use with medical devices, such as catheter devices or systems. The device or system comprises an anchor for securing to tissue. The anchor comprises a series of segments that allow the anchor to be actuated from a delivery configuration to a deployed configuration. The anchor may include a tie band and a free end. In some examples, the device or system is used in treating a diseased native valve in a patient. The anchor may part of a delivery device to implant a prosthetic valve. Subsequent to delivery, the components of the delivery device are actuated to secure the prosthetic valve within the diseased valve.

Systems and methods for building a landing zone for an endovascular procedure are described. This procedure is “hybrid” in that it involves both direct access (e.g., sternotomy or partial sternotomy) to the site for installation of the landing zone, as well as endovascular installation of a TAVR or TEVAR device (e.g., stent graft) once the landing zone is installed. The landing zone is installed by wrapping a landing band around a portion of a vessel. The landing band may be selected to be fixed at a diameter so that it inhibits any expansion of the vessel, and also supports a later-installed TAVR or TEVAR device. The TAVR or TEVAR device is then endovascularly delivered to the vessel and deployed therein. The device expands until it contacts the vessel, which is supported from the outside by the landing band, which thus constrains and supports the device from outside.

Braces having elastic portions that can be made effectively inelastic, based on a level of comfort or support desired by a user, via an inelastic tightening mechanism are disclosed. Some contemplated braces have lumbar supports that are at made at least in part of an elastic material, and inelastic tightening systems that extend across the elastic material and can decrease the effective elasticity of the elastic material to provide greater support.

Disclosed is a false lumen closure assembly for closing a false lumen in a body vessel including a compressed false lumen occluder, a carrier catheter and a retractable sheath. The compressed false lumen occluder includes a stent graft including at least one occlusive barrier across the stent graft to occlude blood flow through an interior of the stent graft. The carrier catheter carries the false lumen occluder and extends from a proximal end proximal of the false lumen occluder to a distal end distal of the false lumen occluder, and passes the false lumen occluder exteriorly of the stent graft. The compressed false lumen occluder and at least part of the carrier catheter are disposed in a lumen of the retractable sheath.

A coronary stent is disclosed herein as having a lattice configuration on a generally thin-walled cylindrical tube. This particular stent is fabricated using an elongated thin-walled tubular solid that has a diameter equal to that of the final expanded configuration of the stent. In other words, the lattice configuration is cut onto the surface of the tubular solid that has a diameter substantially equal to the inner diameter of the blood vessel for which the stent is intended. The tubular lattice is then shrunk (collapsed) axisymmetrically to a new cylindrical configuration with a diameter substantially less than the blood vessel for which the stent is intended. The stent in its reduced diameter state can then be delivered to a desired site in the body via a catheter with an inflatable balloon at its distal portion. Upon the inflation of the balloon, the stent will assume its expanded, deployed configuration into the original diameter at the desired site in the body.

Various embodiments of an implant delivery systems including at least one removable actuator to reshape a valve annulus are described. The systems may use the removable actuator to customize annular reshaping at a treatment site and withdraw the actuator from the treatment site following custom reshaping to provide a low profile annuloplasty implant.

Artificial heart valves, their manufacture, and methods of use are described. Generally, artificial heart valves can be deployed to replace or supplement defective heart valves in a patient. These artificial heart valves can comprise a frame with an inner skirt and leaflets. These inner skirt and leaflets can be generated from regenerative tissue to allow integration of the tissue with the body of a patient, while the frame can be generated from bioabsorbable material to allow dissolution of the frame over time. This combination of materials may allow for the artificial valve to grow with a patient and avoid costly and potentially dangerous replacement for patients receiving artificial valves.

In some examples, the disclosure describes an annuloplasty device that comprises a tube-like structure configured to extend around at least part of a circumference of an annulus of a cardiac or vascular valve of a patient, and at least one anchor configured to anchor the tube-like structure to the annulus. The tube-like structure is configured to decrease a distance between valve leaflets that extend from the annulus.

Some embodiments described herein include a heart valve replacement system that may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, a prosthetic heart valve of the system includes structural features that securely anchor the prosthetic heart valve to the site of the native heart valve. Such structural features can provide robust migration resistance. In particular implementations, the prosthetic heart valves occupy a smaller delivery profile, thereby facilitating a smaller delivery catheter for advancement to the heart.

The invention relates to an endoprosthesis (1), in particular a vascular stent or a heart stent, comprising at least one body (3) part. At least one area (5,6) of an outer surface, preferably the whole outer surface, of the at least one body part (3) is provided with thrombogenic fibers (2). The invention further relates to methods of manufacturing endoprostheses (1).